Scientists develop a potential antibiotic from Komodo dragon blood

  29 October 2020

Komodo dragon blood may hold the key to tackling the “looming crisis” of antimicrobial resistance, according to scientists behind a potential new antibiotic, DRGN-6.

The synthetic molecule, developed by experts at George Mason University in the United States, was created by combining two genes found in Komodo dragon blood – an endangered species found on five Indonesian islands. 

In preclinical tests DRGN-6 killed carbapenem-resistant Klebsiella pneumoniae, a highly drug resistant bacteria which causes a particularly aggressive form of pneumonia. 

 

Further reading: The Telegraph
Author(s): Sarah Newey, Jordan Kelly-Linden
Smart Innovations  
Back

OUR UNDERWRITERS

Unrestricted financial support by:

LifeArc

Antimicrobial Resistance Fighter Coalition

Bangalore Bioinnovation Centre

INTERNATIONAL FEDERATION PHARMACEUTICAL MANUFACTURERS & ASSOCIATIONS





AMR NEWS

Every two weeks in your inbox

Because there should be one newsletter that brings together all One Health news related to antimicrobial resistance: AMR NEWS!

Subscribe

What is going on with AMR?
Stay tuned with remarkable global AMR news and developments!

Keep me informed